Clinical Trials Logo

Over Active Bladder clinical trials

View clinical trials related to Over Active Bladder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02299544 Completed - Over Active Bladder Clinical Trials

BlueWind Medical System for the Treatment of Patients With OAB

OAB
Start date: February 2015
Phase: N/A
Study type: Interventional

BlueWind system safety and performance in treatment of patients diagnosed with overactive bladder (OAB)

NCT ID: NCT02186041 Completed - Clinical trials for Urinary Incontinence

Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study

SOUNDS
Start date: August 2014
Phase:
Study type: Observational

The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy for up to 5 years in a representative sample of French centers under real-life conditions of use.

NCT ID: NCT01672190 Completed - Clinical trials for Urinary Incontinence

Lessening Incontinence by Learning Yoga

LILY
Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the feasibility of recruiting women with urinary incontinence into a randomized controlled trial of a yoga therapy program.

NCT ID: NCT01318837 Completed - Over Active Bladder Clinical Trials

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

RESORT-2
Start date: April 2010
Phase: Phase 4
Study type: Interventional

This study is to evaluate change of over active bladder symptom scores (OABSS) between, before and after solifenacin treatment to OAB subjects.

NCT ID: NCT01260311 Completed - Over Active Bladder Clinical Trials

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Start date: February 2011
Phase: N/A
Study type: Observational

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.